Latest news
Loading news…
89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.
89bio was acquired by Roche in 2025 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
62
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Francisco, California, United States
Key People at 89bio
Chief Financial Officer
Chief Technical Operations Officer and Head of Quality
CEO
Chief Medical Officer
Chief Operating Officer and Chief Business Officer
62
professional contacts at 89bio
Contact execs at 89bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to 89bio
Loading news…
FAQs about 89bio
People who checked this page also checked these
Browse the full Acquirezy directory.